<i>In Vitro</i> Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of <i>Candida glabrata</i> , <i>Candida auris</i> , <i>Cryptococcus neoformans</i> , and <i>Pneumocystis</i> sppGeorge Tetz, Victor Tetz, Margaret S. Collins et al.|Antimicrobial Agents and Chemotherapy|2019Cited by 23
In vitro activity of a novel compound, Mul-1867, against clinically significant fungi Candida spp. and Aspergillus spp.George Tetz, Victor Tetz, Michael H. Cynamon et al.|International Journal of Antimicrobial Agents|2017Cited by 11
Draft Genome Sequence of Streptococcus halitosis sp. nov., Isolated from the Dorsal Surface of the Tongue of a Patient with HalitosisGeorge Tetz, Victor Tetz, Daria Vikina et al.|Microbiology Resource Announcements|2019Cited by 7
Antimicrobial activity of mul-1867, a novel antimicrobial compound, against multidrug-resistant Pseudomonas aeruginosaGeorge Tetz, Victor Tetz, Daria Vikina|Annals of Clinical Microbiology and Antimicrobials|2016Cited by 6
<i>In vitro</i> activity of a novel antifungal compound, MYC-053, against clinically significant antifungal-resistant strains of <i>Candida glabrata, Candida auris, Cryptococcus neoformans</i> , and <i>Pneumocystis</i> sppGeorge Tetz, Victor Tetz, Margaret S. Collins et al.|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 1